879
Views
3
CrossRef citations to date
0
Altmetric
Studies in humans

The effect of a Mediterranean diet vs. a low-fat diet on non-alcoholic fatty liver disease in children: a randomized trial

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 357-366 | Received 31 May 2021, Accepted 08 Sep 2021, Published online: 25 Sep 2021

References

  • Abenavoli L, Boccuto L, Federico A, Dallio M, Loguercio C, Di Renzo L, De Lorenzo A. 2019. Diet and non-alcoholic fatty liver disease: the Mediterranean way. Int J Environ Res Public Health. 16(17):3011.
  • Arsik I, Frediani JK, Frezza D, Chen W, Ayer T, Keskinocak P, Jin R, Konomi JV, Barlow SE, Xanthakos SA, et al. 2018. Alanine aminotransferase as a monitoring biomarker in children with nonalcoholic fatty liver disease. Children. 5(6):64.
  • Astrup A. 2001. The role of dietary fat in the prevention and treatment of obesity. Efficacy and safety of low-fat diets. Int J Obes. 25(S1):S46–S50.
  • Azekour K, Outaleb Z, Eddouks M, Khallouki F, El Bouhali B. 2020. Adherence to the Mediterranean diet of school-age children in Moroccan oases, Draa-Tafilalet region. East Mediterr Health J. 26(9):1070–1077.
  • Barlow SE, Expert C, Expert Committee. 2007. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 120(Suppl 4):S164–S192.
  • Bjermo H, Iggman D, Kullberg J, Dahlman I, Johansson L, Persson L, Berglund J, Pulkki K, Basu S, Uusitupa M, et al. 2012. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am J Clin Nutr. 95(5):1003–1012.
  • Cohen JC, Horton JD, Hobbs HH. 2011. Human fatty liver disease: old questions and new insights. Science. 332(6037):1519–1523.
  • Davis C, Bryan J, Hodgson J, Murphy K. 2015. Definition of the Mediterranean diet; a literature review. Nutrients. 5;7(11):9139–9153.
  • Eckard C, Cole R, Lockwood J, Torres DM, Williams CD, Shaw JC, Harrison SA. 2013. Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial. Therap Adv Gastroenterol. 6(4):249–259.
  • Faul F, Erdfelder E, Buchner A, Lang AG. 2009. Statistical power analyses using G*POWER 3.1: tests for correlation and regression analyses. Behav Res Methods. 41(4):1149–1160.
  • García-Hermoso A, Ramírez-Vélez R, Saavedra JM. 2019. Exercise, health outcomes, and paediatric obesity: a systematic review of meta-analyses. J Sci Med Sport. 22(1):76–84.
  • Gepner Y, Shelef I, Schwarzfuchs D, Zelicha H, Tene L, Yaskolka Meir A, Tsaban G, Cohen N, Bril N, Rein M, et al. 2018. Effect of distinct lifestyle interventions on mobilization of fat storage pools: the central MRI randomized controlled trial. Circulation. 137(11):1143–1157.
  • Goss AM, Dowla S, Pendergrass M, Ashraf A, Bolding M, Morrison S, Amerson A, Soleymani T, Gower B. 2020. Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: a pilot, randomized trial. Pediatr Obes. 15:e12630.
  • Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, Kato T, Takeda N, Okuda J, Ida K, et al. 2007. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterology. 102(12):2708–2715.
  • Katsagoni CN, Georgoulis M, Papatheodoridis GV, Panagiotakos DB, Kontogianni MD. 2017. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: a meta-analysis. Metabolism. 68:119–132.
  • Krishnan S, Cooper JA. 2014. Effect of dietary fatty acid composition on substrate utilization and body weight maintenance in humans. Eur J Nutr. 53(3):691–710.
  • Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, Kim YJ, Yoon JH, Cho SH, Sung MW, et al. 2010. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 42(7):503–508.
  • Lomonaco R, Sunny NE, Bril F, Cusi K. 2013. Nonalcoholic fatty liver disease: current issues and novel treatment approaches. Drugs. 73(1):1–14.
  • Moosavian SP, Arab A, Paknahad Z. 2020. The effect of a Mediterranean diet on metabolic parameters in patients with non-alcoholic fatty liver disease: a systematic review of randomized controlled trials. Clin Nutr Espen. 35:40–46.
  • Neyzi O, Bundak R, Gökçay G, Günöz H, Furman A, Darendeliler F, Baş F. 2015. Reference values for weight, height, head circumference, and body mass index in Turkish children. J Clin Res Pediatr Endocrinol. 7(4):280–293.
  • Panera N, Barbaro B, Della Corte C, Mosca A, Nobili V, Alisi A. 2018. A review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver disease. Nutr Res. 58:1–16.
  • Parra-Vargas M, Rodriguez-Echevarria R, Jimenez-Chillaron JC. 2020. Nutritional approaches for the management of nonalcoholic fatty liver disease: an evidence-based review. Nutrients. 12(12):3860.
  • Perumpail BJ, Cholankeril R, Yoo ER, Kim D, Ahmed A. 2017. An overview of dietary interventions and strategies to optimize the management of non-alcoholic fatty liver disease. Diseases. 5(4):E23.
  • Piers LS, Walker KZ, Stoney RM, Soares MJ, O'Dea K. 2003. Substitution of saturated with monounsaturated fat in a 4-week diet affects body weight and composition of overweight and obese men. Br J Nutr. 90(3):717–727.
  • Plaz Torres MC, Aghemo A, Lleo A, Bodini G, Furnari M, Marabotto E, Miele L, Giannini EG. 2019. Mediterranean diet and NAFLD: what we know and questions that still need to be answered. Nutrients. 11(12):2971.
  • Properzi C, O'Sullivan TA, Sherriff JL, Ching HL, Jeffrey GP, Buckley RF, Tibballs J, MacQuillan GC, Garas G, Adams LA. 2018. Ad libitum Mediterranean and low-fat diets both significantly reduce hepatic steatosis: a randomized controlled trial. Hepatology. 68(5):1741–1754.
  • Rachakonda V, Wills R, DeLany JP, Kershaw EE, Behari J. 2017. Differential impact of weight loss on nonalcoholic fatty liver resolution in a north american cohort with obesity. Obesity. 25(8):1360–1368.
  • Ramon-Krauel M, Salsberg SL, Ebbeling CB, Voss SD, Mulkern RV, Apura MM, Cooke EA, Sarao K, Jonas MM, Ludwig DS. 2013. A low-glycemic-load versus low-fat diet in the treatment of fatty liver in obese children. Child Obes. 9(3):252–260.
  • Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, O'Dea K, Desmond PV, Johnson NA, Wilson AM. 2013. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 59(1):138–143.
  • Salomone F, Ivancovsky-Wajcman D, Fliss-Isakov N, Webb M, Grosso G, Godos J, Galvano F, Shibolet O, Kariv R, Zelber-Sagi S. 2020. Higher phenolic acid intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease. JHEP Rep. 2(2):100069.
  • Schofield WN. 1985. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr. 39(Suppl 1):5–41.
  • Schwimmer JB, Lavine JE, Wilson LA, Neuschwander-Tetri BA, Xanthakos SA, Kohli R, Barlow SE, Vos MB, Karpen SJ, Molleston JP, NASH CRN, et al. 2016. In children with nonalcoholic fatty liver disease, cysteamine bitartrate delayed release improves liver enzymes but does not reduce disease activity scores. Gastroenterology. 151(6):1141–1154.
  • Selvakumar PKC, Kabbany MN, Alkhouri N. 2018. Nonalcoholic fatty liver disease in children: not a small matter. Paediatr Drugs. 20(4):315–329.
  • Tilg H, Hotamisligil GS. 2006. Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology. 131(3):934–945.
  • Tutar O, Beşer ÖF, Adaletli I, Tunc N, Gulcu D, Kantarci F, Mihmanli I, Cokugras FC, Kutlu T, Ozbay G, et al. 2014. Shear wave elastography in the evaluation of liver fibrosis in children. J Pediatr Gastroenterol Nutr. 58(6):750–755.
  • Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, Friedman SL, Diago M, Romero-Gomez M. 2015. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 149(2):367–378.
  • Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, Mouzaki M, Sathya P, Schwimmer JB, Sundaram SS, et al. 2017. NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 64(2):319–334.
  • Vuppalanchi R, Jain AK, Deppe R, Yates K, Comerford M, Masuoka HC, Neuschwander-Tetri BA, Loomba R, Brunt EM, Kleiner DE, et al. 2014. Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 12(12):2121–2130.
  • Yang M, Gong S, Ye SQ, Lyman B, Geng L, Chen P, Li DY. 2014. Non-alcoholic fatty liver disease in children: focus on nutritional interventions. Nutrients. 6(11):4691–4705.
  • Zelber-Sagi S, Salomone F, Mlynarsky L. 2017. The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: evidence and plausible mechanisms. Liver Int. 37(7):936–949.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.